Today's guest is Fred Manby, CTO and Co-founder of Iambic Therapeutics. Iambic uses algorithms to drive a high-throughput experimental platform that specializes in developing new drug discovery techniques. Fred joins us on today's program to discuss the evolving landscape of drug discovery in life sciences. With AI playing an increasingly critical role, the conversation explores the biggest challenges facing drug discovery workflows and how life sciences leaders can better leverage data-driven tools to address them. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!